US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ONCO

Onconetix (ONCO)

Onconetix Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ONCO

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/17	20 : 03	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ONCO	Onconetix Inc
2024/12/13	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ONCO	Onconetix Inc
2024/12/13	07 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ONCO	Onconetix Inc
2024/12/13	07 : 00	GlobeNewswire Inc.	Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing	NASDAQ:ONCO	Onconetix Inc
2024/12/12	07 : 11	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:ONCO	Onconetix Inc
2024/12/11	20 : 24	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ONCO	Onconetix Inc
2024/12/11	06 : 47	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:ONCO	Onconetix Inc
2024/12/04	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ONCO	Onconetix Inc
2024/11/16	01 : 25	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:ONCO	Onconetix Inc
2024/11/16	00 : 45	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:ONCO	Onconetix Inc
2024/11/13	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ONCO	Onconetix Inc
2024/11/13	03 : 48	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:ONCO	Onconetix Inc
2024/11/13	00 : 53	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:ONCO	Onconetix Inc
2024/11/02	06 : 06	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:ONCO	Onconetix Inc
2024/11/02	06 : 05	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:ONCO	Onconetix Inc
2024/11/02	05 : 56	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	NASDAQ:ONCO	Onconetix Inc
2024/11/01	05 : 20	Edgar (US Regulatory)	Form DEF 14C - Other definitive information statements	NASDAQ:ONCO	Onconetix Inc
2024/10/22	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ONCO	Onconetix Inc
2024/10/19	05 : 10	Edgar (US Regulatory)	Form PRE 14C - Other preliminary information statements	NASDAQ:ONCO	Onconetix Inc
2024/10/18	00 : 53	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:ONCO	Onconetix Inc
2024/10/10	06 : 16	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ONCO	Onconetix Inc
2024/10/04	05 : 45	GlobeNewswire Inc.	Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit	NASDAQ:ONCO	Onconetix Inc
2024/10/03	22 : 39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ONCO	Onconetix Inc
2024/10/03	22 : 05	GlobeNewswire Inc.	Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit	NASDAQ:ONCO	Onconetix Inc
2024/10/02	05 : 35	Edgar (US Regulatory)	Form SC 13D - General Statement of Acquisition of Beneficial Ownership	NASDAQ:ONCO	Onconetix Inc
2024/10/02	05 : 35	Edgar (US Regulatory)	Form SC 13D - General Statement of Acquisition of Beneficial Ownership	NASDAQ:ONCO	Onconetix Inc
2024/10/01	08 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ONCO	Onconetix Inc
2024/10/01	08 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ONCO	Onconetix Inc
2024/10/01	08 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ONCO	Onconetix Inc
2024/09/28	04 : 54	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:ONCO	Onconetix Inc

Showing the most relevant articles for your search:NASDAQ:ONCO

1 2 3 次へ >>

Bank of America

US Dollar vs Euro

Energy Select Sector SPDR

US Dollar vs Yen

Deutsche Telekom (QX)

Health Care Select Sector

Financial Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約